Journal
AIDS RESEARCH AND HUMAN RETROVIRUSES
Volume 25, Issue 12, Pages 1243-1248Publisher
MARY ANN LIEBERT INC
DOI: 10.1089/aid.2009.0013
Keywords
-
Categories
Funding
- A. Lorenz at the Ludwig-Maximilians-University of Munich
- Bristol Myers Squibb Foundation, New York
Ask authors/readers for more resources
Metabolic disturbances such as dyslipidemia, lipodystrophy syndrome, visceral obesity, hyperlactatemia, diabetes mellitus, and hepatic steatosis have been recognized as serious complications in long-term antiretroviraltreated HIV-infected patients. The oxidative capacity of liver mitochondria plays a central role in their pathogenesis and can be analyzed using the [C-13] methionine breath test. We analyzed hepatic mitochondrial function using the [C-13] methionine breath test in antiretrovirally treated and untreated HIV-infected patients as well as HIV-negative controls. Patients with hepatic steatosis, hypertriglyceridemia, lipohypertrophy, and older age showed reduced methionine metabolism. Hepatic mitochondrial function is impaired in antiretroviraltreated HIV-infected patients with disturbances of lipid metabolism.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available